Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Grey: Effect of hormone replacement therapy on bone mineral density in postmenopausal women.... (0.15 sec) 

Effect of hormone replacement therapy on bone mineral density in postmenopausal women …

- annals.org
AB Grey, JP Stapleton, MC Evans, MA Tatnell, … - Annals of internal medicine, 1996 - Am Coll Physicians
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Most patients with primary hyperparathyroidism are ...
Cited by 79 - Related articles - All 5 versions

Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year …

- endojournals.org
CR Parker, PJ Blackwell, KJ Fairbairn, DJ … - Journal of Clinical Endocrinology & Metabolism, 2002 - Endocrine Soc
We investigated the effect of alendronate on calcium, PTH, and bone mineral
density in 27 female and 5 male patients with primary hyperparathyroidism. The
treatment group [n = 14; T score -2.5 SD at the femoral neck (FN) or T -1.0 ...
Cited by 43 - Related articles - BL Direct - All 6 versions

Oral alendronate increases bone mineral density in postmenopausal women with primary …

- endojournals.org
CC Chow, WB Chan, JKY Li, NN Chan, MHM … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc
PRIMARY HYPERPARATHYROIDISM (PHP) is common, with an incidence estimated to be
277 per million in Western populations and a higher prevalence in postmenopausal
women (1). It has been increasingly diagnosed since the introduction of ...
Cited by 63 - Related articles - BL Direct - All 6 versions

Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women …

- endojournals.org
MR Rubin, KH Lee, DJ McMahon, SJ … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc
Estrogen replacement therapy (ERT) decreases total serum calcium by about 0.5
mg/dl in postmenopausal women with primary hyperparathyroidism (PHPT). We
investigated the ability of raloxifene, which has skeletal antiresorptive ...
Cited by 65 - Related articles - BL Direct - All 6 versions

Effects of oral alendronate in elderly patients with osteoporosis and mild primary …

- pipex.com [PDF] 
M ROSSINI, D GATTI, G ISAIA, L SARTORI, … - Journal of Bone and Mineral Research, 2001 - Am Soc Bone Min Res
A publication of the American Society for Bone and Mineral Research. Hello.
Sign in to personalize your visit. New user? Register now. ...
Cited by 64 - Related articles - BL Direct - All 8 versions

Effects of hormone replacement therapy on bone mineral density in postmenopausal women …


BJ Orr-Walker, MC Evans, JM Clearwater, A … - Archives of Internal Medicine, 2000 - archinte.highwire.org
Background Long-term treatment of patients with asymptomatic primary
hyperparathyroidism remains controversial, but the presence of osteoporosis is
regarded as an indication for parathyroidectomy. Hormone replacement ...
Cited by 46 - Related articles - BL Direct - All 5 versions

Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with …


CA Reasner, MD Stone, DJ Hosking, A … - Journal of Clinical Endocrinology & Metabolism, 1993 - Endocrine Soc
Page 1. 0021-972x/93/7704-1067)03.00/0 Journal of Clinical Endocrinology end Met&&am
Copyright 0 1993 hy The Endocrine Society Vol. 77, No. 4 Printed in USA ...
Cited by 45 - Related articles - BL Direct - All 5 versions

Estrogen replacement may be an alternative to parathyroid surgery for the treatment of …


T Diamond, ATM Ng, S Levy, C Magarey, R … - Osteoporosis International, 1996 - Springer
Abstract. Parathyroid surgery is indicated in patients presenting with primary
hyperparathyroidism (PHPT) and osteoporosis (defined as bone mineral density
more than 2 standard deviations below normal). Many are elderly women with ...
Cited by 20 - Related articles - BL Direct - All 4 versions

Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary …


JR ZANCHETTA, CE BOGADO - Journal of Bone and Mineral Research, 2001 - Am Soc Bone Min Res
Here, we report the effects of 12 months of treatment with raloxifene, 60 mg/day
or 120 mg/day, on lumbar spine and femur neck bone mineral density (BMD) and
biochemical parameters in 3 postmenopausal osteopenic women (mean age, 64; ...
Cited by 30 - Related articles - BL Direct - All 6 versions

Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism


R MARCUS, P MADVIG, M CRIM, A PONT, … - Annals of internal medicine, 1984 - Am Coll Physicians
Fourteen postmenopausal women with mild hyperparathyroidism were given
conjugated estrogens. Serum calcium levels became normal and urinary calcium
excretion was reduced for up to 2 years in ten patients taking an average ...
Cited by 67 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google